Hylton NM - Search Results

1

Residual Disease after Neoadjuvant Therapy for Breast Cancer: Can MRI Help?

Hylton NM. Hylton NM. Radiology. 2018 Nov;289(2):335-336. doi: 10.1148/radiol.2018181846. Epub 2018 Aug 28. Radiology. 2018. PMID: 30152746 Free PMC article. No abstract available.

2

Impact of section doubling on MR angiography.

Hylton NM, Simovsky I, Li AJ, Hale JD. Hylton NM, et al. Radiology. 1992 Dec;185(3):899-902. doi: 10.1148/radiology.185.3.1438782. Radiology. 1992. PMID: 1438782

3

Echo-planar pediatric imager.

Crooks LE, Arakawa M, Hylton NM, Avram H, Hoenninger JC, Watts JC, Hale JD, Kaufman L. Crooks LE, et al. Among authors: hylton nm. Radiology. 1988 Jan;166(1 Pt 1):157-63. doi: 10.1148/radiology.166.1.3336674. Radiology. 1988. PMID: 3336674

4

Semi-automated analysis for MRI of breast tumors.

Partridge SC, Heumann EJ, Hylton NM. Partridge SC, et al. Among authors: hylton nm. Stud Health Technol Inform. 1999;62:259-60. Stud Health Technol Inform. 1999. PMID: 10538368

5

Challenges to interpretation of breast MRI.

Kinkel K, Hylton NM. Kinkel K, et al. Among authors: hylton nm. J Magn Reson Imaging. 2001 Jun;13(6):821-9. doi: 10.1002/jmri.1117. J Magn Reson Imaging. 2001. PMID: 11382939 Review.

6

MRI phenotype is associated with response to doxorubicin and cyclophosphamide neoadjuvant chemotherapy in stage III breast cancer.

Esserman L, Kaplan E, Partridge S, Tripathy D, Rugo H, Park J, Hwang S, Kuerer H, Sudilovsky D, Lu Y, Hylton N. Esserman L, et al. Ann Surg Oncol. 2001 Jul;8(6):549-59. doi: 10.1007/s10434-001-0549-8. Ann Surg Oncol. 2001. PMID: 11456056

7

Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy.

Partridge SC, Gibbs JE, Lu Y, Esserman LJ, Sudilovsky D, Hylton NM. Partridge SC, et al. Among authors: hylton nm. AJR Am J Roentgenol. 2002 Nov;179(5):1193-9. doi: 10.2214/ajr.179.5.1791193. AJR Am J Roentgenol. 2002. PMID: 12388497

8

MRI measurements of breast tumor volume predict response to neoadjuvant chemotherapy and recurrence-free survival.

Partridge SC, Gibbs JE, Lu Y, Esserman LJ, Tripathy D, Wolverton DS, Rugo HS, Hwang ES, Ewing CA, Hylton NM. Partridge SC, et al. Among authors: hylton nm. AJR Am J Roentgenol. 2005 Jun;184(6):1774-81. doi: 10.2214/ajr.184.6.01841774. AJR Am J Roentgenol. 2005. PMID: 15908529

9

Diagnostic architectural and dynamic features at breast MR imaging: multicenter study.

Schnall MD, Blume J, Bluemke DA, DeAngelis GA, DeBruhl N, Harms S, Heywang-Köbrunner SH, Hylton N, Kuhl CK, Pisano ED, Causer P, Schnitt SJ, Thickman D, Stelling CB, Weatherall PT, Lehman C, Gatsonis CA. Schnall MD, et al. Radiology. 2006 Jan;238(1):42-53. doi: 10.1148/radiol.2381042117. Radiology. 2006. PMID: 16373758

10

MR imaging for assessment of breast cancer response to neoadjuvant chemotherapy.

Hylton N. Hylton N. Magn Reson Imaging Clin N Am. 2006 Aug;14(3):383-9, vii. doi: 10.1016/j.mric.2006.09.001. Magn Reson Imaging Clin N Am. 2006. PMID: 17098179 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

191 results

Search Page